Asia-Pacific Healthcare: Managing Diversity
The Asia-Pacific region is a vast geographic area, home to almost half of the world’s population and numerous emerging and developed markets with great investment potential for healthcare and life…
Address: 2 Chia Ping Road, # 09-01 Singapore 619968 ,Singapore
Tel: +65 6265 2777
Web: http://www.dha.asia/
Drug Houses of Australia Pte Ltd. (DHA) is a subsidiary of Watson Pharmaceuticals, Inc., New Jersey, USA., and operates an extensive network of pharmaceutical business operations in Southeast Asia. Watson Pharmaceuticals, Inc. is a leading integrated generic pharmaceutical company grossing a revenue of USD4.6 billion in 2011, and currently has operations spread across the globe.
DHA has already become a household name, with a strong brand build upon premium products, manufactured at their own facilities in Singapore and at other global sites via contract manufacturing. They ensure consistent high quality and reliability in every single product, and their manufacturing sites include those approved by stringent requirements of regulatory authorities such as USFDA, TGA & MHRA
Generic Drugs
The Asia-Pacific region is a vast geographic area, home to almost half of the world’s population and numerous emerging and developed markets with great investment potential for healthcare and life…
Singapore has pioneered multiple aspects of QuintilesIMS’s global business, and the high profile merger has created interesting opportunities for the organization within the APAC region, beyond strong synergies at the…
Peter Ulvskjold, the Corporate Vice President of International Operations in Southeast Asia, highlights the challenges in the region facing diabetics and how Novo Nordisk is working to close the gaps…
In an exclusive interview with Tom Page, the Vice President of Contract Logistics and Health Care Asia pacific at UPS, he emphasizes the strategic importance of Singapore as a logistics…
With healthcare demand rapidly increasing in Asia Pacific and worldwide, the entire healthcare sector is sure to undergo a dramatic revolution. J&J Medical’s Chairman for Asia Pacific discusses his priorities…
As the world’s best airport, Changi Airport is also a fast growing hub for pharma freight shipping, and has demonstrated significant leadership in the world of pharma logistics hubs while…
What role has Southeast Asia played within Evonik’s global business since you became regional president? Peter Meinshausen (PM): Considering Southeast Asia to consist of the ASEAN countries, we have seen…
In an exclusive interview with Brent Scott, President of Asia for Stryker, he highlights the growth potential of the region, Stryker’s aggressive acquisition strategy, and the strategic partnerships in the…
In an exclusive interview with Leslie Chua, the General Manager of the Solutions Division at Hitachi Medical Systems, he elaborates on how the division is building on the synergies of…
DKSH’s VP of Healthcare in Singapore and Malaysia, Dr. Varun Sethi deconstructs the essence of what it means to be a Market Expansion Services provider, while highlighting aspects of the…
The chairman of Singapore’s Medical Technology Industry Group, Albert Lee discusses the association’s key priorities, how they serve to advance the interests of both multinational and local members, and the…
In an exclusive interview, Zuellig Pharma CEO John Davison provides insight into the new Zuellig Health Solutions unit that is providing strategic, topline-focused services in order to support Pharma companies…
See our Cookie Privacy Policy Here
